Details and Uses:
- Targeted Condition: Used for bladder and urinary tract cancers that have spread or cannot be removed by surgery.
- Genetic Requirement: It is only used for patients whose tumor has specific genetic alterations in the FGFR3 or FGFR2 genes. A healthcare provider will perform a genetic test to confirm the presence of these changes before starting the medication.
- Prior Treatment: Typically prescribed for patients who have already received at least one course of platinum-containing chemotherapy and whose cancer has progressed.
- Method of Use: It is taken orally. Dosage is determined by an oncologist based on individual patient assessment, which may include adjustments based on tolerability.
Reviews
There are no reviews yet.